O TYM ODCINKU

Język angielski
Stany Zjednoczone

TRANSKRYPCJA 🔗

WYSZUKAJ MINIONE ODCINKI

Wyszukaj minione odcinki Medical Digest & Congress Report.

INNE ODCINKI W TYM PODCASCIE

Dr. Stefano Del Prato presents key findings from the Phase 3 TRIUMPH-2 trial evaluating retatrutide at the EASD 2026 Congress. This brief highlights clinical evidence on the glycemic efficacy, weight reduction outcomes, and safety profile of triple receptor agonism in adults living with obesity and…
Dr. Paolo Sbraccia presents key insights into viewing obesity as a systemic disease and adopting a biology-driven approach to metabolic health at the EASD 2026 Congress. This brief highlights the pathophysiological progression from adiposity to systemic metabolic dysfunction, emphasizing targeted t…
Dr. Martin Haluzík presents key findings from the REIMAGINE 2 trial evaluating CagriSema at the EASD 2026 Congress. This brief highlights clinical data on the impact of dual amylin and GLP-1 receptor agonism on bone turnover markers, overall bone health, and metabolic parameters in participants wit…
Dr. Katherine Tuttle presents key insights on cardiorenal protection in type 2 diabetes at the EASD 2026 Congress, drawing from both the FLOW and ACHIEVE-4 trials. This brief highlights novel proteomic biomarker analyses explaining the pathways of kidney protection in FLOW, alongside clinical data …
Dr. John Bernard Buse presents key updates from the joint ADA/EASD consensus report on the management of type 2 diabetes at the EASD 2026 Congress. This brief highlights updated clinical guidelines, person-centered management strategies, holistic care approaches, and evidence-based recommendations …
Zastrzeżenie: Podcast i grafika osadzone na tej stronie pochodzą z Medical Congress News, który jest własnością jego właściciela i nie jest powiązany ani wspierany przez Listen Notes, Inc.